Evidence map›Paper›PMID 35722460›Full record

ArticleBioMed research international2022

Towards the First Multiepitope Vaccine Candidate against

Morteza Shams, Bahman Maleki, Bahareh Kordi, Hamidreza Majidiani, Naser Nazari, Hamid Irannejad, Ali Asghari

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Microorganisms · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. BioMed research international · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Morteza ShamsZoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.ORCID https://orcid.org/0000-0001-7124-4908
Bahman MalekiDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Bahareh KordiDepartment of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran.
Hamidreza MajidianiDepartment of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran.ORCID https://orcid.org/0000-0001-5568-1366
Naser NazariDepartment of Parasitology and Mycology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.ORCID https://orcid.org/0000-0001-7989-1536
Hamid IrannejadDepartment of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0001-7513-6162
Ali AsghariDepartment of Medical Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0002-4005-2687
University of Neyshabur · IRKermanshah University of Medical Sciences · IRMazandaran University of Medical Sciences · IRMedical University of Ilam · IRShiraz University of Medical Sciences · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoccidiosisNeosporaProtozoan VaccinesAnimalsAntigens, ProtozoanCattleFemaleInterferon-gammaMicePregnancyToll-Like Receptor 4Antigens, ProtozoanInterferon-gammaProtozoan VaccinesToll-Like Receptor 4

Identifiers

PMID35722460
PMCPMC9204498
OpenAlexW4285740142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.